Surgical management of sporadic medullary thyroid cancer

J Visc Surg. 2011 Sep;148(4):e244-9. doi: 10.1016/j.jviscsurg.2011.07.009. Epub 2011 Aug 31.

Abstract

Inherited and sporadic medullary thyroid cancer (MTC) is a rare carcinoma. Sporadic MTCs represent 70% of cases. Diagnosis is currently made with the routine use of serum calcitonin (CT) measurements to screen patients with nodular thyroid disease. Surgery is the only curative treatment of MTC and since cervical lymph nodes metastases are frequent and can occur at an early stage, a standardized lymph node dissection should be associated to total thyroidectomy. However, the extent of lymphadenectomy remains debated. Prognosis of MTC is related to both the stage of the disease and the extent of initial surgery. When tumor remnants persist after surgery, there are very few therapeutic alternatives, and these are generally of limited curative value.

Publication types

  • Review

MeSH terms

  • Calcitonin / blood
  • Carcinoma, Medullary / blood
  • Carcinoma, Medullary / diagnosis
  • Carcinoma, Medullary / surgery*
  • Humans
  • Lymph Node Excision
  • Lymphatic Metastasis
  • Prognosis
  • Survival Rate
  • Thyroid Neoplasms / blood
  • Thyroid Neoplasms / diagnosis
  • Thyroid Neoplasms / surgery*
  • Thyroidectomy / methods*

Substances

  • Calcitonin